Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Metabolic & Weight Management · Philadelphia, PA
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, investigated by Philadelphia-area research teams for metabolic and weight-management studies. It for research use only is documented by ReVia for institutions and independent investigators throughout the region's pharma corridor. Material is third-party COA tested so researchers can verify quality before work begins.
A triple-hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Studies have investigated its multi-receptor pharmacology and effects on metabolic signaling pathways.
Along the Northeast pharma and research corridor, Philadelphia laboratories study retatrutide as a triple-agonist peptide of interest for incretin-pathway modeling. Teams in King of Prussia, Cherry Hill, and Wilmington apply it to receptor-affinity and intracellular-signaling assays in cultured systems, working with the compound strictly as preclinical material for non-clinical, bench-level investigation.
Retatrutide is worked with by researchers throughout the Philadelphia metro — including King of Prussia, Cherry Hill, Wilmington, Camden — and across East Coast. The Northeast's pharma and research corridor. Every ReVia-branded lot carries its own certificate of analysis, and the compound is intended strictly for research use.
Where do researchers in labs near Philadelphia obtain Retatrutide?
These compounds are supplied through i2b Health, ReVia's research partner, to researchers in Philadelphia and surrounding areas including King of Prussia, Cherry Hill, and Wilmington for research use only. Each shipment includes tracking details.
What testing documentation comes with Retatrutide?
Each batch carries a third-party Certificate of Analysis documenting purity and identity. Researchers can review the COA prior to use.
What is Retatrutide investigated for?
Retatrutide is investigated in research contexts as a triple receptor agonist relevant to metabolic and weight-management studies. It is offered strictly for laboratory research and not for any clinical purpose.
For research use only. Not for human or veterinary use. The information on this page is provided for educational and research purposes and does not constitute medical advice.